Restaurant Industry Has Mixed Views on GLP-1 Drugs -- Market Talk

Dow Jones
01/15

1816 ET - Restaurants shared mixed commentary related to GLP-1 drugs at the ICR Conference, Baird analysts say in a note. Darden Restaurants thinks full-service restaurants may remain relatively well insulated from rising adoption of the drugs, reasoning that GLP-1s tend to reduce impulse food purchases rather than dining out, the analysts say. Portillo's, meanwhile, acknowledges some risk from the drugs, but it's been tough to parse out the effect so far, the analysts say. "Altogether, management teams did not seem overly concerned about this topic," the analysts say, noting that companies see the potential to emphasize certain areas of their menus to respond to any changes in consumer preferences. (kelly.cloonan@wsj.com)

 

(END) Dow Jones Newswires

January 14, 2026 18:16 ET (23:16 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10